skip to content

Annual Results

Biotech GT NAV rises 27.5%

25 May 2017 13:54

The Biotech Growth Trust has reported that its net asset value per share rose by 27.5%, during the year ended 31 March 2017, compared to the Company's benchmark, the NASDAQ Biotechnology Index (sterling adjusted), which rose by 29.2%.

The share price rose by 27.9% over the period, which the Company said reflects a slight narrowing in the discount of the share price to net asset value per share, from 6.8% at the start of the year, to 6.6% at 31 March 2017.

At 1:53pm: (LON:BIOG) Biotech Gwth share price was +4.75p at 706.25p

Story provided by StockMarketWire.com

Related Company: BIOG

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.